Baker Bros. Advisors as of June 30, 2021
Portfolio Holdings for Baker Bros. Advisors
Baker Bros. Advisors holds 120 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seagen | 32.8 | $7.5B | 47M | 157.88 | |
| BeiGene Sponsored Adr (ONC) | 17.6 | $4.0B | 12M | 343.19 | |
| Incyte Corporation (INCY) | 11.8 | $2.7B | 32M | 84.13 | |
| Kodiak Sciences (KOD) | 5.8 | $1.3B | 14M | 93.00 | |
| ACADIA Pharmaceuticals (ACAD) | 4.5 | $1.0B | 42M | 24.39 | |
| BioMarin Pharmaceutical (BMRN) | 2.8 | $633M | 7.6M | 83.44 | |
| Ascendis Pharma A/S Sponsored Adr | 2.0 | $466M | 3.5M | 131.55 | |
| Invitae (NVTAQ) | 1.5 | $346M | 10M | 33.73 | |
| argenx SE Sponsored Adr (ARGX) | 1.5 | $337M | 1.1M | 301.07 | |
| Prelude Therapeutics (PRLD) | 1.3 | $290M | 10M | 28.63 | |
| Igm Biosciences (IGMS) | 1.2 | $263M | 3.2M | 83.20 | |
| Abcellera Biologics (ABCL) | 1.0 | $230M | 11M | 22.00 | |
| Mirati Therapeutics | 1.0 | $228M | 1.4M | 161.53 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $201M | 13M | 15.81 | |
| Madrigal Pharmaceuticals (MDGL) | 0.6 | $146M | 1.5M | 97.41 | |
| Apellis Pharmaceuticals | 0.6 | $144M | 2.3M | 63.20 | |
| Heron Therapeutics (HRTX) | 0.6 | $126M | 8.1M | 15.52 | |
| Amarin Corporation Sponsored Adr | 0.5 | $116M | 27M | 4.38 | |
| Global Blood Therapeutics In | 0.5 | $113M | 3.2M | 35.02 | |
| Pacific Biosciences of California (PACB) | 0.5 | $112M | 3.2M | 34.97 | |
| Immunocore Holdings Ads (IMCR) | 0.4 | $98M | 2.5M | 39.05 | |
| Kymera Therapeutics (KYMR) | 0.4 | $95M | 2.0M | 48.50 | |
| Verastem | 0.4 | $88M | 22M | 4.07 | |
| Verve Therapeutics (VERV) | 0.4 | $85M | 1.4M | 60.25 | |
| Talis Biomedical Corp | 0.4 | $84M | 7.6M | 11.03 | |
| Cerus Corporation (CERS) | 0.4 | $81M | 14M | 5.91 | |
| DBV Technologies Sponsored Adr | 0.4 | $80M | 15M | 5.46 | |
| Rhythm Pharmaceuticals (RYTM) | 0.3 | $76M | 3.9M | 19.58 | |
| Instil Bio | 0.3 | $75M | 3.9M | 19.32 | |
| Legend Biotech Corporation Sponsored Ads (LEGN) | 0.3 | $68M | 1.7M | 41.05 | |
| Neurocrine Biosciences (NBIX) | 0.3 | $66M | 677k | 97.32 | |
| Nurix Therapeutics (NRIX) | 0.3 | $65M | 2.5M | 26.53 | |
| Insmed Incorporated Com Par $.01 (INSM) | 0.3 | $61M | 2.2M | 28.46 | |
| Allakos | 0.3 | $60M | 703k | 85.37 | |
| Zymeworks | 0.3 | $59M | 1.7M | 34.69 | |
| Horizon Therapeutics Public SHS | 0.2 | $56M | 599k | 93.64 | |
| Forma Therapeutics Holdings SHS | 0.2 | $50M | 2.0M | 24.89 | |
| Immatics SHS (IMTX) | 0.2 | $50M | 4.3M | 11.61 | |
| Insmed Incorporated Note 0.75% 6/1/2028 (Principal) | 0.2 | $44M | 40M | 1.10 | |
| Merus N V (MRUS) | 0.2 | $43M | 2.0M | 21.07 | |
| Ultragenyx Pharmaceutical (RARE) | 0.2 | $42M | 444k | 95.35 | |
| Adaptimmune Therapeutics Sponsored Adr (ADAPY) | 0.2 | $42M | 9.8M | 4.26 | |
| Krystal Biotech (KRYS) | 0.2 | $41M | 608k | 68.00 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.2 | $39M | 2.8M | 13.93 | |
| Sarepta Therapeutics DBCV 1.5% 11/15/2024 (Principal) | 0.2 | $39M | 29M | 1.32 | |
| Fulgent Genetics (FLGT) | 0.2 | $37M | 401k | 92.23 | |
| Axsome Therapeutics (AXSM) | 0.2 | $36M | 539k | 67.46 | |
| Neoleukin Therapeutics | 0.2 | $35M | 3.8M | 9.23 | |
| Bioatla | 0.2 | $35M | 825k | 42.38 | |
| ADC Therapeutics SA SHS (ADCT) | 0.2 | $35M | 1.4M | 24.35 | |
| Aligos Therapeutics | 0.1 | $33M | 1.6M | 20.39 | |
| Aerovate Therapeutics (AVTE) | 0.1 | $33M | 1.4M | 22.83 | |
| Reata Pharmaceuticals Cl A | 0.1 | $32M | 224k | 141.53 | |
| Novavax (NVAX) | 0.1 | $31M | 144k | 212.31 | |
| Alkermes SHS (ALKS) | 0.1 | $30M | 1.2M | 24.52 | |
| Atreca Cl A Com (BCEL) | 0.1 | $30M | 3.5M | 8.52 | |
| Design Therapeutics (DSGN) | 0.1 | $29M | 1.4M | 19.89 | |
| Apellis Pharmaceuticals Note 3.5% 9/15/2026 (Principal) | 0.1 | $28M | 15M | 1.85 | |
| Tricida Note 3.5% 5/15/2027 (Principal) | 0.1 | $27M | 75M | 0.36 | |
| Opthea Sponsored Ads (OPTEY) | 0.1 | $27M | 3.4M | 7.94 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $25M | 2.6M | 9.79 | |
| Aeglea Biotherapeutics | 0.1 | $24M | 3.4M | 6.96 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $20M | 455k | 44.88 | |
| Cyteir Therapeutics | 0.1 | $17M | 813k | 21.40 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.1 | $17M | 921k | 18.85 | |
| Otonomy | 0.1 | $16M | 7.2M | 2.23 | |
| BioMarin Pharmaceutical Note 0.599% 8/1/2024 (Principal) | 0.1 | $16M | 15M | 1.04 | |
| Chinook Therapeutics | 0.1 | $15M | 1.1M | 14.12 | |
| Aurinia Pharmaceuticals (AUPH) | 0.1 | $15M | 1.1M | 12.96 | |
| Albireo Pharma | 0.1 | $15M | 413k | 35.18 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $14M | 752k | 18.62 | |
| Invitae Corporation Note 2.0% 9/1/2024 (Principal) | 0.1 | $14M | 10M | 1.35 | |
| Mirum Pharmaceuticals (MIRM) | 0.0 | $11M | 647k | 17.29 | |
| Anaptysbio Inc Common (ANAB) | 0.0 | $11M | 427k | 25.93 | |
| Edgewise Therapeutics (EWTX) | 0.0 | $11M | 500k | 21.33 | |
| Altimmune (ALT) | 0.0 | $11M | 1.1M | 9.85 | |
| Cymabay Therapeutics | 0.0 | $9.5M | 2.2M | 4.36 | |
| Genetron Holdings Ads | 0.0 | $9.2M | 455k | 20.14 | |
| Centessa Pharmaceuticals Sponsored Ads | 0.0 | $8.9M | 400k | 22.21 | |
| Iveric Bio | 0.0 | $8.9M | 1.4M | 6.31 | |
| Athira Pharma (ATHA) | 0.0 | $8.3M | 806k | 10.24 | |
| Assembly Biosciences | 0.0 | $8.2M | 2.1M | 3.88 | |
| Karuna Therapeutics Ord | 0.0 | $8.0M | 70k | 113.98 | |
| Mereo BioPharma Group Ads (MREO) | 0.0 | $7.8M | 2.5M | 3.17 | |
| Silverback Therapeutics (SPRY) | 0.0 | $7.4M | 238k | 30.89 | |
| Bluebird Bio | 0.0 | $7.3M | 227k | 31.98 | |
| Revolution Medicines (RVMD) | 0.0 | $7.1M | 222k | 31.74 | |
| Denali Therapeutics (DNLI) | 0.0 | $7.0M | 89k | 78.44 | |
| Chiasma | 0.0 | $6.7M | 1.4M | 4.73 | |
| Hookipa Pharma Inc equity | 0.0 | $6.4M | 701k | 9.16 | |
| Burning Rock Biotech Sponsored Ads | 0.0 | $6.2M | 209k | 29.46 | |
| Replimune Group (REPL) | 0.0 | $5.9M | 154k | 38.42 | |
| Ngm Biopharmaceuticals | 0.0 | $5.8M | 292k | 19.72 | |
| Cabaletta Bio (CABA) | 0.0 | $5.5M | 636k | 8.60 | |
| Macrogenics (MGNX) | 0.0 | $5.4M | 201k | 26.86 | |
| Orchard Therapeutics Ads | 0.0 | $5.2M | 1.2M | 4.39 | |
| Alector (ALEC) | 0.0 | $5.0M | 239k | 20.83 | |
| Neximmune | 0.0 | $4.8M | 294k | 16.32 | |
| Biomea Fusion (BMEA) | 0.0 | $4.6M | 294k | 15.61 | |
| Gamida Cell SHS | 0.0 | $3.9M | 611k | 6.41 | |
| Iteos Therapeutics | 0.0 | $3.9M | 150k | 25.65 | |
| Harmony Biosciences Hldgs In (HRMY) | 0.0 | $3.5M | 124k | 28.23 | |
| Tricida | 0.0 | $3.2M | 729k | 4.32 | |
| Evofem Biosciences | 0.0 | $3.0M | 2.7M | 1.13 | |
| Akero Therapeutics (AKRO) | 0.0 | $2.9M | 118k | 24.81 | |
| Tcr2 Therapeutics Inc cs | 0.0 | $2.9M | 177k | 16.41 | |
| Acceleron Pharma | 0.0 | $2.8M | 22k | 125.50 | |
| Travere Therapeutics (TVTX) | 0.0 | $2.7M | 187k | 14.59 | |
| Relmada Therapeutics (RLMD) | 0.0 | $2.5M | 77k | 32.01 | |
| Logicbio Therapeutics | 0.0 | $2.0M | 452k | 4.44 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $1.9M | 200k | 9.74 | |
| Inozyme Pharma (INZY) | 0.0 | $1.8M | 107k | 17.04 | |
| Passage Bio | 0.0 | $1.6M | 117k | 13.24 | |
| Affimed Therapeutics B V | 0.0 | $1.4M | 165k | 8.50 | |
| Oyster Point Pharma | 0.0 | $1.1M | 61k | 17.19 | |
| Leap Therapeutics | 0.0 | $918k | 560k | 1.64 | |
| Bellicum Pharmaceuticals | 0.0 | $822k | 249k | 3.30 | |
| Kezar Life Sciences | 0.0 | $758k | 140k | 5.43 | |
| Frequency Therapeutics | 0.0 | $553k | 56k | 9.95 | |
| Syros Pharmaceuticals | 0.0 | $357k | 66k | 5.45 |